KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Acquisitions (2016 - 2025)

Merck (MRK) has disclosed Acquisitions for 14 consecutive years, with $10.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Acquisitions rose 847.17% to $10.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $10.0 billion, a N/A change, with the full-year FY2025 number at $10.0 billion, changed N/A from a year prior.
  • Acquisitions was $10.0 billion for Q4 2025 at Merck, up from -$1.3 billion in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $10.0 billion in Q4 2025 to a low of -$1.3 billion in Q4 2024.
  • A 4-year average of $1.0 billion and a median of $83.0 million in 2021 define the central range for Acquisitions.
  • Biggest YoY gain for Acquisitions was 12200.0% in 2022; the steepest drop was 234.44% in 2022.
  • Merck's Acquisitions stood at $90.0 million in 2021, then crashed by 234.44% to -$121.0 million in 2022, then tumbled by 1010.74% to -$1.3 billion in 2024, then skyrocketed by 847.17% to $10.0 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Acquisitions are $10.0 billion (Q4 2025), -$1.3 billion (Q4 2024), and $598.0 million (Q3 2024).